[1]
Algethami, M.D., Alzahrani, S.A., Alessa, B.H., Madhi, A.N.B., Alzahrani, H.M. and Altwairqi, R.S. 2024. Sodium‐glucose co‐transporter protein 2 inhibitors for long-term kidney function preservation in type 2 diabetes with chronic kidney disease: a meta-analysis of rates of progression to end-stage renal disease. International Journal Of Community Medicine And Public Health. 12, 1 (Dec. 2024), 407–413. DOI:https://doi.org/10.18203/2394-6040.ijcmph20243771.